Welcome to our dedicated page for Eastman Chem Co SEC filings (Ticker: EMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Eastman Chemical Company (EMN) SEC filings page provides access to the company’s regulatory disclosures as a public issuer on the New York Stock Exchange. As a global specialty materials company in the plastics material and resin manufacturing industry, Eastman files periodic and current reports that describe its financial condition, results of operations, governance matters, and material events.
Among the most closely watched documents are annual reports on Form 10-K and quarterly reports on Form 10-Q, which include segment information, discussions of end-market demand in areas such as transportation, building and construction, and consumables, and commentary on topics like cash generation, cost structure, and specialty materials performance. Current reports on Form 8-K provide timely updates on specific events, including quarterly earnings releases, Board and executive changes, and other matters the company deems material.
Investors can also review proxy statements for information on Board composition, committee assignments, and director compensation, as well as filings related to executive compensation and governance. For those monitoring insider activity, Forms 3, 4, and 5 disclose transactions by directors and officers in Eastman’s common stock.
On this page, AI-powered tools summarize lengthy filings, highlight key sections, and help explain complex topics such as non-GAAP measures like adjusted EBIT and adjusted earnings per diluted share that Eastman discusses in its earnings materials. Real-time updates from the SEC’s EDGAR system ensure that new EMN filings, including 10-K, 10-Q, 8-K, and Form 4 submissions, are available quickly, allowing users to review the underlying disclosures and the AI-generated insights side by side.
Eastman Chemical Company executive Brad A. Lich reported equity awards granted as part of his compensation. On February 24, 2026, he acquired employee stock options for 63,123 shares of common stock at a grant price of $0 per option.
One-third of these options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029. He also received 8,684 restricted stock units, each representing one share of common stock, which will vest and pay out in unrestricted shares on February 24, 2029, subject to continued employment.
McLain William Thomas Jr. reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical executive vice president and CFO William Thomas McLain Jr. reported equity awards consisting of 59,801 employee stock options and 8,227 restricted stock units, both granted at a price of $0 per unit.
One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029. Each restricted stock unit represents the right to receive one share of common stock and will vest and pay out in unrestricted shares on February 24, 2029, subject to continued employment.
Eastman Chemical Company has issued $600,000,000 aggregate principal amount of 4.500% notes due February 20, 2031 in a public offering. The notes pay interest semi-annually on February 20 and August 20, starting August 20, 2026.
Before January 20, 2031, Eastman may redeem the notes at the greater of a make-whole amount based on the Treasury Rate plus 15 basis points or 100% of principal, plus accrued interest. On and after January 20, 2031, the notes are callable at 100% of principal, plus accrued interest.
The notes are senior unsecured obligations, ranking equally with other unsecured, unsubordinated Eastman debt and effectively junior to secured and subsidiary liabilities. If a change of control plus ratings downgrade occurs, holders can require Eastman to repurchase the notes at 101% of principal plus accrued interest. Net proceeds of approximately $593.7 million are earmarked for general corporate purposes, including working capital, capital expenditures, debt repayment and strategic initiatives.
Eastman Chemical Company executive Brad A. Lich, EVP & CCO, reported a tax-related share disposition on common stock. On February 18, 2026, 5,569 shares were withheld at $80.26 per share to cover tax obligations tied to the payout of performance shares for the 2023–2025 performance period. After this transaction, he directly owned 96,779 common shares, with additional indirect holdings through an ESOP and a 401(k) plan.
Eastman Chemical Company senior vice president Adrian James Holt reported a routine tax-withholding share disposition. On this Form 4, 588 shares of common stock were withheld at a price of $80.26 per share to cover tax obligations from the payout of performance shares for the 2023-2025 performance period. After this non-market transaction, Holt directly holds 1,709 shares of Eastman Chemical common stock.
Eastman Chemical Company executive reports tax-related share withholding. EVP, AFP, Mfg., WWEC & HSE Brian Travis Smith had 3,086 shares of common stock withheld at $80.26 per share on a tax-withholding disposition related to performance shares for the 2023–2025 performance period, leaving him with 24,235 directly owned shares.
Eastman Chemical Company senior vice president Julie A. McAlindon reported a tax-related share disposition involving company common stock. On February 18, 2026, 1,812 shares of common stock were withheld at $80.26 per share to satisfy tax obligations tied to a performance share payout for the 2023-2025 performance period.
After this withholding, McAlindon directly owned 18,199 shares of Eastman Chemical common stock. She also indirectly held 887 shares through an ESOP arrangement, reflecting separate plan-related ownership.
Eastman Chemical Company senior vice president Michelle H. Caveness had 528 shares of common stock withheld on February 18, 2026 to cover tax obligations tied to a performance share payout for the 2023–2025 period.
After this tax-withholding disposition, she directly owned 7,655 shares of Eastman Chemical common stock.
Eastman Chemical Company Controller and Chief Accounting Officer Michelle Renee Stewart reported a tax-related share disposition. On the reported date, 1,063 shares of common stock were withheld at a price of $80.26 per share to cover tax obligations tied to the payout of performance shares for the 2023-2025 performance period. After this withholding, her directly owned common stock holdings were 7,209 shares.
Eastman Chemical executive vice president and CFO William Thomas McLain Jr. reported a tax-related share disposition involving company common stock. On the reported date, 4,471 shares were withheld at a price of $80.26 per share to cover tax obligations tied to the payout of performance shares for the 2023–2025 performance period. After this tax-withholding disposition, he directly held 65,313 shares of Eastman Chemical common stock.